Value in Health
October–November 2017 Volume 20, Issue 9
Cost-Effectiveness of Additional Vaccination of Boys Against HPV In Germany
O Damm, J Horn, B Ultsch, S Scholz, R Mikolajczyk, M Wiese-Posselt, T Harder, O Wichmann, W Greiner
Published in issue: October-November, 2017
Routine vaccination of girls against human papillomavirus (HPV) was introduced in Germany in 2007. In an independently funded model-based study, HPV vaccination of girls was found to be a cost-effective intervention in Germany. However, the cost-effectiveness of vaccinating boys remained unclear, particularly because the previous study did not consider all relevant aspects (i.e. two-dose schedule, broader spectrum of HPV-associated cancers, ninevalent vaccine). The objective of this study was to estimate the cost-effectiveness of adding boys to the existing immunisation strategy in Germany.